|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM061562238 |
| 003 |
DE-627 |
| 005 |
20231221220016.0 |
| 007 |
tu |
| 008 |
231221s1982 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed24n0205.xml
|
| 035 |
|
|
|a (DE-627)NLM061562238
|
| 035 |
|
|
|a (NLM)6179101
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Pogliani, E M
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Beta-thromboglobulin and platelet factor 4 plasma levels during haemodialysis
|b effect of indobufen
|
| 264 |
|
1 |
|c 1982
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 17.09.1982
|
| 500 |
|
|
|a Date Revised 15.11.2012
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a The effect of a single dose of indobufen (100 mg i.v.) on the release of beta-thromboglobulin and of the platelet factor 4 was investigated during dialysis in 20 uraemic subjects by a within-subjects, single-blind, indobufen versus placebo study. Plasma levels were measured in baseline conditions and 15, 30, 60, 120 and 240 minutes after the beginning of dialysis. Pre-treatment with indobufen clearly inhibited beta-TG and PF 4 output. The difference from placebo was highly significant (p less than 0.01) from the 30-minute control up to the end of dialysis. No changes in platelet count before and after dialysis were observed
|
| 650 |
|
4 |
|a Clinical Trial
|
| 650 |
|
4 |
|a Controlled Clinical Trial
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
7 |
|a Beta-Globulins
|2 NLM
|
| 650 |
|
7 |
|a Blood Coagulation Factors
|2 NLM
|
| 650 |
|
7 |
|a Indoles
|2 NLM
|
| 650 |
|
7 |
|a Isoindoles
|2 NLM
|
| 650 |
|
7 |
|a Phenylbutyrates
|2 NLM
|
| 650 |
|
7 |
|a beta-Thromboglobulin
|2 NLM
|
| 650 |
|
7 |
|a Platelet Factor 4
|2 NLM
|
| 650 |
|
7 |
|a 37270-94-3
|2 NLM
|
| 650 |
|
7 |
|a indobufen
|2 NLM
|
| 650 |
|
7 |
|a 6T9949G4LZ
|2 NLM
|
| 700 |
1 |
|
|a Colombi, M
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Cristoforetti, G
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Valenti, G
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Miradoli, R
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Buccianti, G
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)
|d 1995
|g 3(1982), 2 vom: 27., Seite 127-32
|w (DE-627)NLM023961570
|
| 773 |
1 |
8 |
|g volume:3
|g year:1982
|g number:2
|g day:27
|g pages:127-32
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_31
|
| 912 |
|
|
|a GBV_ILN_39
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_72
|
| 912 |
|
|
|a GBV_ILN_120
|
| 912 |
|
|
|a GBV_ILN_121
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 3
|j 1982
|e 2
|b 27
|h 127-32
|